Effects of Selenium Supplementation on Cardiometabolic Risk Factors, Inflammatory, and Antioxidant Markers: A Systematic Review and Meta-analysis Protocol.
Antioxidant markers
cardiometabolic risk factors
inflammatory markers
selenium
supplementation
systematic review
Journal
International journal of preventive medicine
ISSN: 2008-7802
Titre abrégé: Int J Prev Med
Pays: Iran
ID NLM: 101535380
Informations de publication
Date de publication:
2019
2019
Historique:
received:
23
11
2017
accepted:
19
11
2018
entrez:
14
1
2020
pubmed:
14
1
2020
medline:
14
1
2020
Statut:
epublish
Résumé
Selenium (Se) is considered as an antioxidant trace element involved in key activities in human metabolism. Recent investigations indicate that Se plays a pivotal role in human health. Se supplementation considered as an intervention is both cost-effective and simple-to-use that may play an important role in the prevention of cardiometabolic risk factors (CRFs), inflammatory, and antioxidant markers. This paper is a protocol study on systematic review of probable effects of Se supplementation on CRFs, inflammatory, and antioxidant markers. The aim was to achieve three international databases available related to the current publications including, PubMed, ISI/WOS, and Scopus. We attempted to search for randomized clinical trials (RCT) and cross-over trials pertaining to human subjects without any restriction on language and time. In addition, there was no limitation on the age of participants. For RCTs were included all studies in different target groups comprising diabetic patients, patients with polycystic ovarian syndrome, obese subjects, or even healthy controls. To investigate the effect of Se, we included all studies which Se is used either as single therapy or as combination therapy. All studies associated with articles and meta-analyses would be evaluated to review their references. The current study contained numerous outcomes. The result of this study can be led to make reliable scientific evidence on the probable effects of Se supplementation on CRFs, inflammatory factors, and antioxidant factors. In addition to these findings, other technical documents developed for a systematic review can be used for future studies.
Sections du résumé
BACKGROUND
BACKGROUND
Selenium (Se) is considered as an antioxidant trace element involved in key activities in human metabolism. Recent investigations indicate that Se plays a pivotal role in human health. Se supplementation considered as an intervention is both cost-effective and simple-to-use that may play an important role in the prevention of cardiometabolic risk factors (CRFs), inflammatory, and antioxidant markers.
METHODS
METHODS
This paper is a protocol study on systematic review of probable effects of Se supplementation on CRFs, inflammatory, and antioxidant markers. The aim was to achieve three international databases available related to the current publications including, PubMed, ISI/WOS, and Scopus. We attempted to search for randomized clinical trials (RCT) and cross-over trials pertaining to human subjects without any restriction on language and time. In addition, there was no limitation on the age of participants. For RCTs were included all studies in different target groups comprising diabetic patients, patients with polycystic ovarian syndrome, obese subjects, or even healthy controls. To investigate the effect of Se, we included all studies which Se is used either as single therapy or as combination therapy. All studies associated with articles and meta-analyses would be evaluated to review their references.
CONCLUSIONS
CONCLUSIONS
The current study contained numerous outcomes. The result of this study can be led to make reliable scientific evidence on the probable effects of Se supplementation on CRFs, inflammatory factors, and antioxidant factors. In addition to these findings, other technical documents developed for a systematic review can be used for future studies.
Identifiants
pubmed: 31929860
doi: 10.4103/ijpvm.IJPVM_509_17
pii: IJPVM-10-213
pmc: PMC6941376
doi:
Types de publication
Journal Article
Langues
eng
Pagination
213Informations de copyright
Copyright: © 2019 International Journal of Preventive Medicine.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Am J Ther. 2014 Nov-Dec;21(6):491-5
pubmed: 23633679
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Zhong Xi Yi Jie He Xue Bao. 2010 Jul;8(7):604-12
pubmed: 20619135
BMJ Open. 2016 Sep 28;6(9):e011920
pubmed: 27683514
Horm Metab Res. 2016 Mar;48(3):185-90
pubmed: 26267328
Arch Iran Med. 2014 Dec;17(12):830-6
pubmed: 25481322
Stat Med. 2009 Jan 30;28(2):221-39
pubmed: 19012297
Circulation. 2002 Jul 16;106(3):286-8
pubmed: 12119239
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Horm Metab Res. 2009 Jun;41(6):443-7
pubmed: 19418416
Stat Med. 1991 Nov;10(11):1665-77
pubmed: 1792461
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
BMC Med Res Methodol. 2005 Apr 20;5:13
pubmed: 15840177
J Dig Dis. 2011 Oct;12(5):333-40
pubmed: 21091931
Nutr J. 2015 Feb 18;14:18
pubmed: 25880386
Can J Diet Pract Res. 2005 Summer;66(2):98-102
pubmed: 15975198
Circulation. 2004 Apr 13;109(14):e180
pubmed: 15078809
Biol Trace Elem Res. 2013 Dec;156(1-3):22-8
pubmed: 24150923
Sao Paulo Med J. 2015 Mar-Apr;133(2):164-5
pubmed: 26018887
BMJ Open Diabetes Res Care. 2016 Aug 12;4(1):e000253
pubmed: 27547419
Lancet. 2005 Apr 16-22;365(9468):1415-28
pubmed: 15836891
Curr Opin Clin Nutr Metab Care. 2014 Jan;17(1):40-4
pubmed: 24241129
Ann N Y Acad Sci. 1990;587:123-39
pubmed: 2193564
Biol Trace Elem Res. 2008 Summer;123(1-3):58-65
pubmed: 18288450